Resource Library

We’ve compiled a useful collection of resources to learn more about Medrio and various aspects of managing your clinical trial in today’s complex and evolving environment.

  • Filter by Solution

  • Filter by Content

HEADER GRAPHIC 26Feb25 How EU AI Act Affects Clinical Trials
Blog
CDMS / EDC

How the EU AI Act Affects Clinical Trials

February 24, 2025
In this blog, explore how the EU AI Act impacts clinical trials, from risk classification to compliance strategies.
HEADER GRAPHIC 05Feb25 What is eSource in Clinical Trials
Blog
CDMS / EDCDCTeCOA / ePROeConsent

What is eSource in Clinical Trials

February 3, 2025
In this blog, discover what eSource is, how it works, and why it benefits clinical trials.
HEADER GRAPHIC 31Jan25 Milestone Guide to UAT Success
Infographic
CDMS / EDC

UAT in Clinical Trials Guide

In this infographic, learn best practices for navigating user acceptance testing (UAT) for smoother, more efficient database builds.
AI press release header
News

Medrio Launches AI-Enabled Reporting, Tackling Increasing Data Challenges in Clinical Trials

SAN FRANCISCO, CA – January 29, 2025—Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled reporting, an innovative new capability available within Medrio CDMS/EDC. Medrio’s...
HEADER GRAPHIC 15Jan25 How AI in Clinical Trials Shapes the Future
Blog
CDMS / EDCDCTeCOA / ePROeConsentRTSM

How AI in Clinical Trials Shapes the Future

January 13, 2025
In this blog, discover how AI is rippling through every segment of clinical trials and how to navigate the new landscape.
Xtalks Banner Image
Webinar
CDMS / EDCDCT

Navigating Early-Phase Clinical Trials: Key Considerations for Emerging Biotech and MedTech

This webinar explores the essential strategies and solutions for efficiently navigating clinical trial data collection, technology integration, and strategic planning to achieve FDA approval and secure payer reimbursement.

Enter a topic, term or keyword below:

Subscribe to our mailing list

Sign up to have our the latest insights delivered to your inbox.